Sleep is associated with tau pathology in early Alzheimer’s disease

By | Community Events, In the News | No Comments

Colleagues at Washington University School of Medicine published novel findings on the correlation between tau tangles, a hallmark of Alzheimer’s disease pathology, and sleep quality in people who were cognitively normal or who had mild cognitive impairment. On ALZFORUM, UCI MIND faculty member, Dr. Bryce Mander commented, “This is an important paper because it shows for the first time how tau is related to sleep deficits. That’s going to be important in advancing our understanding of how Alzheimer’s disease pathology affects sleep.” Dr. Mander, Assistant Professor of Psychiatry & Human Behavior at UCI, has published several important findings on the link between…

Read More

Washington Post article highlights need for Latino representation in Alzheimer’s clinical studies (Written in English & Spanish)

By | Commentary | No Comments

Washington Post article highlights need for Latino representation in Alzheimer’s clinical studies Contributed by Christian Salazar, PhD, UCI MIND Associate Project Scientist A rare form of Alzheimer’s disease, caused by a gene mutation first discovered among people living in Jalisco, Mexico, develops at much earlier age than typical cases of Alzheimer’s disease. Andres Martin, a 31-year old Marine, has this ‘Jalisco mutation’, and is committed to raising awareness that the fight against Alzheimer’s disease does not only impact older adults. He’s especially motivated to protect those like his daughter, Alexis, a 2-year old who has a 50% chance of inheriting…

Read More

Dr. Ira Lott, Director of UCI MIND Down Syndrome Program, featured in OC Business Journal

By | Carousel Slider, In the News | No Comments

Dr. Ira Lott, Director of the UCI MIND Down Syndrome Program, discussed the connection between Down syndrome and Alzheimer’s disease with the Orange County Business Journal this week.  Dr. Lott and his team conduct critical research studies with volunteer participants to improve understanding of brain aging and dementia in Down syndrome. Click here to read the article > To learn more about studies in Down syndrome and Alzheimer’s disease, click here >

Read More

Critical need for diversity in Alzheimer’s disease research

By | Commentary, In the News | No Comments

Contributed by Joshua Grill, PhD, Director of UCI MIND In a new study, colleagues at the Alzheimer’s Disease Research Center at Washington University have found that levels of the cerebrospinal fluid protein tau, one of the hallmark pathologies in Alzheimer’s disease (AD), is lower in African Americans compared to Whites. This was true both for older participants who did and did not have memory problems. The study is not the first to find such differences between African Americans and Caucasians and it has important implications to a number of important areas of AD research. First, there is a growing movement…

Read More

UCI MIND Raises Record-Breaking $370K at 9th Annual Gala

By | Community Events | No Comments

IRVINE, Calif. (Dec. 11, 2018) – UCI MIND, the University of California, Irvine’s Institute for Memory Impairments and Neurological Disorders, Orange County’s only state and federally designated Alzheimer’s Disease Research Center (ADRC), hosted its 9th annual A December to Remember Gala on Saturday, December 1 at the Balboa Bay Resort in Newport Beach. UCI MIND raised a record-shattering $370,000 through underwriting, ticket sales and donations from the attendees. “UCI MIND would not be at the forefront of Alzheimer’s disease research without the strong community behind us,” notes Dr. Joshua Grill, Director of UCI MIND. “We are forever grateful for the…

Read More

Novel genetics research opens door to potential new therapies for dementia

By | Carousel Slider, In the News | No Comments

UCI MIND faculty member, Dr. Vivek Swarup, and colleagues at UCLA, Takeda Pharmaceutical Co. Ltd. in Japan, Emory University School of Medicine, Harvard Medical School, and the Perelman School of Medicine at the University of Pennsylvania, published novel findings yesterday in Nature Medicine on two major groups of genes associated  with Alzheimer’s disease and frontotemporal dementia and unraveled a novel microRNA, miR-203, as a master regulator of neuronal death. In human cell cultures containing AD-associated mutations, the researchers showed that certain experimental drugs altered the loss of brain cells associated with neurodegenerative disease. Dr. Swarup says, “I’m hopeful these important findings will bring us one step closer to effective new treatments…

Read More

Fall 2018 Newsletter – In this issue of MIND Matters

By | In the News | No Comments

Fall 2018 Newsletter – In this issue of MIND Matters: – Grand Opening of UCI Sleep Center led by Dr. Ruth Benca – Wine for the MIND hosted by Bob & Virginia Naeve – Meet the REMIND Co-Chairs – Study Partners in Alzheimer’s Research: Gwen Ritchie – Philanthropist Highlight: Greg & Cindy Lai – Donations, Sept 2017-2018 —– Click to read the Fall 2018 Newsletter – MIND Matters

Read More